Exchange: NYSE·Updated 07:30 PM EDT
CSL logo

CSL Carlisle Companies Inc.

$320.36
$0.89
(0.28%)
Today
Closed $320.36
$0.00
(0.00%)
After Hours
EarningsOct 28
Mkt Cap$12.76B
Vol336,932.00

About CSL

Carlisle Cos., Inc. engages in the design, manufacture, and distribution of building envelope products and energy solutions. It operates through the Carlisle Construction Materials (CCM) and Carlisle Weatherproofing Technologies (CWT) segments. The Carlisle Construction Materials segment produces single-ply roofing products and warranted roof systems and accessories for the commercial building industry, including ethylene propylene diene monomer (“EPDM”), thermoplastic polyolefin (“TPO”) and polyvinyl chloride (“PVC”) membrane, polyiso insulation, and engineered metal roofing and wall panel systems for commercial and residential buildings. The Carlisle Weatherproofing Technologies segment produces spray polyurethane foam technologies, architectural metal, heating, ventilation and air conditioning (HVAC) hardware and sealants, below-grade waterproofing, and air and vapor barrier systems focused on the weatherproofing and thermal performance of the building envelope. The company was founded by Charles S. Moomy in 1917 and is headquartered in Scottsdale, AZ.
50

Neutral Sentiment

How do you feel about CSL?

topstockalerts
CSL announced Tuesday that it has partnered with Amazon Web Services to integrate artificial intelligence and cloud computing across its research and clinical development operations, as the healthcare company seeks to accelerate data-driven drug development. The collaboration is designed to help CSL scientists connect and analyze large volumes of scientific data, identify potential therapeutic targets at earlier stages and evaluate external research and business opportunities more quickly. The companies also aim to create closer links between laboratory experiments and computational research, allowing experimental results to be incorporated into research models and decision-making with less delay. In clinical development, CSL plans to use AWS technology to reduce manual work in areas including protocol drafting, clinical data management and regulatory documentation. $CSL $AMZN

Advertisement|Remove ads.